Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Sex Disparities in Neuro-Ophthalmologic Disorders.
Prospect of brain-machine interface in motor disabilities: the future support for multiple sclerosis patient to improve quality of life.
General Mathematical Ability Predicts PASAT Performance in MS Patients: Implications for Clinical Interpretation and Cognitive Reserve.
G protein-coupled receptors as therapeutic targets for multiple sclerosis.
PDLIM2 restricts Th1 and Th17 differentiation and prevents autoimmune disease.
Clinical profile and aetiology of optic neuritis in Hospital Universiti Sains Malaysia--5 years review.
Better look (and think) twice-TNF-alpha-inhibition and multiple sclerosis.
Effect of Tai Chi Chuan on balance in women with multiple sclerosis.
The Neural Stem Cell Microenvironment: Focusing on Axon Guidance Molecules and Myelin-Associated Factors.
School performance as a marker of cognitive decline prior to diagnosis of multiple sclerosis.
Treatment with Vitamin D/MOG Association Suppresses Experimental Autoimmune Encephalomyelitis.
The risk of developing depression when suffering from neurological diseases.
Medical and pharmacy claims-based algorithims for identifying patients with multiple sclerosis.
[Update on diagnosis and treatment of multiple sclerosis.]
Progesterone's role in neuroprotection, a review of the evidence.
SOX17 is expressed in regenerating oligodendrocytes in experimental models of demyelination and in multiple sclerosis.
[Neuromyelitis optica].
Optimizing therapeutics in the management of patients with multiple sclerosis: a review of drug efficacy, dosing, and mechanisms of action.
Robust myelin quantitative imaging from multi-echo T2 MRI using edge preserving spatial priors.
Acute inflammatory myelopathies.
Immunological Mechanism of Action and Clinical Profile of Disease-Modifying Treatments in Multiple Sclerosis.
A 3-year Multi-center Study to Describe Changes of OCT Parameters Under Treatment With Gilenya® (PASSOS)
Oligodendrocytes engineered with migratory proteins as effective graft source for cell transplantation in multiple sclerosis.
Preliminary results after upper cervical chiropractic care in patients with chronic cerebro-spinal venous insufficiency and multiple sclerosis.
Natalizumab reduces relapse clinical severity and improves relapse recovery in MS.

Pages